VIP as a trophic factor in the CNS and cancer cells (Q35063187)

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Co-localization of vasoactive intestinal polypeptide, gamma-aminobutyric acid and choline acetyltransferase in neocortical interneurons of the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide and electrical activity influence neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A femtomolar-acting neuroprotective peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cytokine regulation of neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Characterization of the RDC1 gene which encodes the canine homolog of a proposed human VIP receptor. Expression does not correlate with an increase in VIP binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Characterization of VIP-sensitive adenylate cyclase in guinea pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The PACAP ligand/receptor system regulates cerebral cortical neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Somatostatin receptor subtype gene expression in human and rodent tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Activators of cyclic adenosine 3':5'-monophosphate accumulation in rat hippocampal slices: action of vasoactive intestinal peptide (VIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Conformational study of vasoactive intestinal peptide by computational methods

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Solution structure of an analogue of vasoactive intestinal peptide as determined by two-dimensional NMR and circular dichroism spectroscopies and constrained molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Activity-dependent neurotrophic factor: a potent regulator of embryonic growth and development.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Development of high affinity selective VIP1 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Studies toward the biosynthesis of vasoactive intestinal peptide (VIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A new concept in the pharmacology of neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP-derived sequences modified by N-terminal stearyl moiety induce cell death: the human keratinocyte as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP and PACAP 38 modulate ibotenate-induced neuronal heterotopias in the newborn hamster neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Multiple receptors for PACAP and VIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Phenotypic plasticity in adult sympathetic ganglia in vivo: effects of deafferentation and axotomy on the expression of vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide influences neurite outgrowth in cultured rat spinal cord neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

PACAP-38 protects cerebellar granule cells from apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Modulation of a 190-kD microtubule-associated protein in pigment epithelium by VIP

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

PACAP(6-38) inhibits the growth of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Inhibition of human neuroblastoma growth by a specific VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP gene transcription is regulated by far upstream enhancer and repressor elements

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A paradigm for distinguishing the roles of mitogenesis and trophism in neuronal precursor proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

(Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Neuropeptide expression by newborn and adult rat sensory neurons in culture: effects of nerve growth factor and other neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

High affinity receptors for vasoactive intestinal peptide on a human glioma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal polypeptide (VIP) induces calcium mobilization in the human neuroblastoma cell line SK-N-SH.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide induces differentiation and MAP kinase activation in PC12h cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide regulation of neuroblast mitosis and survival: role of cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal peptide (VIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

LIF-mediated activation of STAT proteins after neuronal injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Peripheral but not central axotomy promotes axonal outgrowth and induces alterations in neuropeptide synthesis in the nodose ganglion of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Insulin-like growth factor gene expression during rat embryonic development

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Polypeptide with Broad Biological Activity: Isolation from Small Intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

High affinity binding of VIP to human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Differential signal transduction by five splice variants of the PACAP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Imaging tumors in humans with Tc-99m-VIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Screening of adrenal medullary neuropeptides for putative neurotrophic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal polypeptide-augmented insulin release: actions on ionic fluxes and electrical activity of mouse islets

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide: an important trophic factor and developmental regulator?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5'-flanking sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Solution structure comparison of the VIP/PACAP family of peptides by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

Vasoactive intestinal peptide: mediator of laminin synthesis in cultured Schwann cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021

(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900290-5

7 January 2021